Leiomyosarcoma (LMS)
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients (NCT07432932) | Royal Marsden NHS Foundation Trust | 2021-11-19 |
| Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies (NCT02822495) | Atara Biotherapeutics |
Track Leiomyosarcoma (LMS) automatically
Every clearance here is in the API, with alerts when new ones post.